Botulinum Toxin A Macro Complex Isolation via pH-Controlled Chromatography
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for isolating botulinum toxin from solutions often result in dissociation of neurotoxic components during purification, particularly affecting the recovery of the botulinum toxin type A macro complex.
Innovation Solution
A method involving anion exchange chromatography at a pH lower than the isoelectric point of botulinum toxin, followed by cation exchange chromatography, allows for the efficient separation and isolation of the botulinum toxin type A macro complex without binding it to the chromatography medium, utilizing specific buffer conditions and resins to maintain the complex's integrity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If conventional chromatography methods are used to isolate botulinum toxin, then purification is achieved, but the neurotoxic components dissociate and are lost during the process
Solution Approach 1:
The patent applies parameter changes by controlling the pH of the buffer solution to be below the isoelectric point of botulinum toxin (pH < 5.0). This pH control prevents the toxin from binding to the anion exchange resin, allowing it to pass through in the flow-through fraction while impurities are retained, thereby preventing dissociation and maintaining high recovery of the neurotoxic macro complex
Solution Approach 2:
The patent extracts the botulinum toxin from the complex mixture by utilizing its specific charge properties at controlled pH. The toxin is selectively removed from impurities through the chromatography process where it appears in the flow-through fraction, achieving separation without dissociation of the neurotoxic components
2Manufacturing precision
If the botulinum toxin is bound to the anion exchange chromatography medium for purification, then separation from impurities is achieved, but the toxin macro complex dissociates
Solution Approach 1:
The patent inverts the conventional approach by preventing binding instead of promoting it. Rather than binding the toxin to the resin for separation, the method allows the toxin to pass through unbound while impurities bind to the resin, achieving separation through the absence of binding rather than through binding itself
Solution Approach 2:
By controlling pH below the isoelectric point, the patent changes the charge state of the toxin to prevent electrostatic interaction with the anion exchange resin, thereby maintaining macro complex integrity while still achieving separation from impurities through differential binding behavior
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method efficiently isolates the botulinum toxin type A macro complex with high purity, preventing dissociation and ensuring effective recovery of the toxin, as demonstrated by the example of Clostridium botulinum toxin purification.
Implementation Method 1
contacting the botulinum toxin-containing solution with an anion exchange chromatography medium at a pH lower than an isoelectric point (pI) of botulinum toxin
Implementation Method 2
contacting the solution, which is not bound to the anion exchange chromatography medium, with a cation exchange chromatography medium
Implementation Method 3
contacting the solution, which is not bound to the anion exchange chromatography medium, with a cation exchange chromatography medium at a pH lower than pI of botulinum toxin
Data Source
Figure 1~2
AI summary
Provided is a method of isolating a botulinum toxin type A macro complex from a botulinum toxin-containing solution, the method including performing anion exchange chromatography and cation exchange chromatography.